Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q2 2015 · 10-Q
Revenue$72.16M$72.16M−3.4% vs Q2 2014 Net Income$6.25M$6.25M+9.2% vs Q2 2014 EPS Diluted$0.51$0.51+15.9% vs Q2 2014 Gross Profit$53,167,000−4.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$7,740,000+36.3% Free Cash Flowderived$7,274,000+85.2% Margins · derivedGross margin73.7%−0.7 pt vs Q2 2014
Operating margin12.0%−1.2 pt vs Q2 2014
Net margin8.7%+1.0 pt vs Q2 2014
ended Jun 30, 2015 · filed Aug 10, 2015 · 41 d after period end